dissection associated with ischemic stroke or TIA. The
number of adverse events does not signiÔ¨Åcantly differ
based on the medical therapy.491 The safety and effectiveness of therapy with alpha-adrenergic antagonist,
angiotensin inhibitor, or nondihydropyridine calcium
channel antagonist to lower blood pressure to normal
and reduce arterial wall stress are not well-established.
By contrast, intervention is reserved for symptomatic
patients with recurrent neurologic symptoms